Previous 10 | Next 10 |
Forte Biosciences (NASDAQ:FBRX) appoints Dr. Hubert Chen, MD as the Chief Scientific Officer and President. Prior to joining the company, Dr. Chen was the Chief Medical Officer of Metacrine. “Dr. Chen is a very accomplished drug development scientist and physician and we...
Forte Biosciences press release (NASDAQ:FBRX): Q1 GAAP EPS of -$0.17. Ended first quarter 2022 with ~$40M in cash and cash equivalents. For further details see: Forte Biosciences GAAP EPS of -$0.17
- Forte Biosciences to Develop Novel Pipeline for the Treatment of Autoimmune Diseases - -Leadership Strengthened with Appointments of Stephen Doberstein, Ph.D. and Barbara Finck, M.D. to the Board of Directors- -Ended first quarter 2022 with approximately $40....
What to Know About Buying Penny Stocks on May 3rd, 2022 After an interesting start to May for penny stocks and blue chips, there is a lot for investors to know right now. While morning gainers like Forte Biosciences Inc. ( NASDAQ: FBRX ) and SoundHound AI Inc. ( NASDAQ: SOUN ) a...
Utilizing its proprietary BOLT and synthetic biology platforms, BiomX develops natural and engineered phage therapeutic cocktails to treat chronic diseases ranging from acne, IBD, PSC, CF, A. Dermatitis and colorectal cancer. BiomX currently has four Phase 2 clinical trial readouts du...
Healthcare stocks in the S&P 500 underperformed the ~1.7% loss in the broader index to end ~2.7% lower over the holiday-shortened week to record their worst weekly performance since November. Among healthcare stocks with more than $300M market cap and over 100K average daily vol...
Gainers: ZIOPHARM Oncology (NASDAQ:ZIOP) +39%, RenovoRx (NASDAQ:RNXT) +17%, Sigilon Therapeutics (NASDAQ:SGTX) +17%, Acumen Pharmaceuticals (NASDAQ:ABOS) +15%, NeuroOne Medical Technologies (NASDAQ:NMTC) +7%. Losers: CorMedix (NASDAQ:CRMD) -25...
CMCM, COUP, FBRX, QTT For Seeking Alpha's full earnings season calendar, click here. For further details see: Notable earnings before Tuesday's open
Listen on the go! A daily podcast of Wall Street Breakfast's Alpha Talks will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify. The stock market closed the week on a relatively risk-off environment even with a much worse-than-expected number of jobs added to the econom...
Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report. Mond...
News, Short Squeeze, Breakout and More Instantly...
Forte Biosciences Inc. Company Name:
FBRX Stock Symbol:
NASDAQ Market:
Forte Biosciences Inc. Website:
Forte Biosciences, Inc. ( www.fortebiorx.com ) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company focused on autoimmune and autoimmune-related diseases, today announced first quarter 2024 results and provided a business update. First Quarter 2024 Business Highlights ȁ...
Forte Biosciences, Inc. ( www.fortebiorx.com ) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company focused on autoimmune and autoimmune-related diseases, today announced its 2023 results and provided a business update. 2023 Business Highlights “Forte achieved a major...